A review of 59 studies finds inconsistent knowledge, attitudes, and practices among health care professionals in detecting diabetic retinopathy. Diabetic retinopathy (DR) remains one of the leading ...
MONDAY, Aug. 18, 2025 (HealthDay News) -- For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review ...
Boehringer Ingelheim has inked a deal with Palatin Technologies worth up to €280 million (about $327 million) biobucks with the aim of developing new retinal disease therapies. The German drugmaker ...
A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...
Some reassuring news for patients taking GLP-1 receptor agonists: Concerns that the drugs may cause retinopathy may be overblown. A new analysis of nearly 160,000 people with diabetes taking four ...
For people with diabetes, high blood sugar can damage blood vessels and nerves, leading to chronic wounds that stay open for months. But a new gel-based treatment could massively speed up the healing ...
ALPHARETTA, Ga., July 23, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead to permanent vision loss if not properly managed. Related: What does an A1C ...
Survival models using electronic health record data show promise in predicting progression to proliferative diabetic retinopathy in patients with type 2 diabetes. Among a cohort of adults with type 2 ...
Hikma is offering triamcinolone acetonide injectable suspension in a 40mg/ml dose. The product is indicated for various inflammatory, autoimmune, hormonal and other conditions where a corticosteroid ...
Here are seven new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in ...
– Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative technology via ...